EQUITEC PROPRIETARY MARKETS, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
EQUITEC PROPRIETARY MARKETS, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2023$644
-3.0%
1,0230.0%0.00%
Q4 2022$664
-66.8%
1,0230.0%0.00%
-100.0%
Q3 2022$2,000
+100.0%
1,0230.0%0.00%
Q2 2022$1,0000.0%1,0230.0%0.00%
Q1 2022$1,000
-94.1%
1,023
-93.5%
0.00%
-100.0%
Q4 2021$17,000
-51.4%
15,723
-17.2%
0.00%
-66.7%
Q3 2021$35,000
-78.9%
19,000
-69.7%
0.01%
-88.0%
Q2 2021$166,000
+50.9%
62,628
+44.1%
0.05%
+78.6%
Q4 2020$110,000
+14.6%
43,476
+13.8%
0.03%
-61.6%
Q3 2020$96,000
-68.2%
38,200
-54.5%
0.07%
-23.2%
Q1 2020$302,000
+395.1%
83,928
+156.7%
0.10%
+295.8%
Q4 2018$61,000
-6.2%
32,700
+61.1%
0.02%
-17.2%
Q3 2018$65,000
-33.7%
20,300
-37.5%
0.03%
+16.0%
Q2 2018$98,000
-60.5%
32,500
-48.8%
0.02%
-67.1%
Q1 2018$248,000
-61.7%
63,442
-59.5%
0.08%
-61.6%
Q4 2017$648,000
-26.7%
156,595
+8.8%
0.20%
-4.3%
Q3 2017$884,000
-28.6%
143,972
-27.7%
0.21%
-26.6%
Q2 2017$1,238,000
+11.7%
199,027
+13.9%
0.28%
+320.9%
Q1 2017$1,108,000
+6.7%
174,800
-9.9%
0.07%
+63.4%
Q4 2016$1,038,000
+54.7%
193,993
+62.8%
0.04%
+28.1%
Q3 2016$671,000
+2136.7%
119,195
+2067.2%
0.03%
+3100.0%
Q2 2016$30,0005,5000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders